- Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer. Yamada, Y., Ohtsu, A., Boku, N., Miyata, Y., Shimada, Y., Doi, T., Muro, K., Muto, M., Hamaguchi, T., Mera, K., Yano, T., Tanigawara, Y., Shirao, K. Jpn. J. Clin. Oncol. (2006)